Completed
A Study to Evaluate the Safety and Immunogenicity of ChAdOx1-VZV in Healthy Adults Aged 50-65 Years
NCT05991427
- Conditions
- Chickenpox, DNA Virus Infections, Herpes Zoster, +9 more
- Locations
-
- Canadian Center for Vaccinology Halifax, Canada